OBSL1
Basic information
Region (hg38): 2:219550728-219571859
Links
Phenotypes
GenCC
Source:
- 3M syndrome 2 (Definitive), mode of inheritance: AR
- 3M syndrome 2 (Strong), mode of inheritance: AR
- 3-M syndrome (Supportive), mode of inheritance: AR
- 3M syndrome 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Three M syndrome 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Endocrine; Musculoskeletal | 19481195; 23457316; 27796265 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (901 variants)
- Inborn_genetic_diseases (358 variants)
- 3M_syndrome_2 (248 variants)
- not_specified (100 variants)
- OBSL1-related_disorder (51 variants)
- 3M_syndrome_1 (3 variants)
- Short_stature (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OBSL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015311.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 280 | 22 | 323 | ||
missense | 623 | 58 | 12 | 694 | ||
nonsense | 11 | 10 | 31 | |||
start loss | 1 | 1 | ||||
frameshift | 20 | 23 | 17 | 61 | ||
splice donor/acceptor (+/-2bp) | 14 | 18 | ||||
Total | 32 | 47 | 672 | 343 | 34 |
Highest pathogenic variant AF is 0.000345412
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OBSL1 | protein_coding | protein_coding | ENST00000404537 | 21 | 21131 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.99e-26 | 0.722 | 123979 | 2 | 1160 | 125141 | 0.00465 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00685 | 1170 | 1.17e+3 | 0.999 | 0.0000776 | 11872 |
Missense in Polyphen | 427 | 426.77 | 1.0005 | 4414 | ||
Synonymous | -0.193 | 517 | 511 | 1.01 | 0.0000347 | 4136 |
Loss of Function | 2.42 | 51 | 73.4 | 0.695 | 0.00000410 | 750 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0166 | 0.0159 |
Ashkenazi Jewish | 0.0154 | 0.0153 |
East Asian | 0.00284 | 0.00278 |
Finnish | 0.00423 | 0.00423 |
European (Non-Finnish) | 0.00368 | 0.00363 |
Middle Eastern | 0.00284 | 0.00278 |
South Asian | 0.00161 | 0.00157 |
Other | 0.00666 | 0.00657 |
dbNSFP
Source:
- Function
- FUNCTION: Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695, PubMed:24793696). Acts as a regulator of the Cul7-RING(FBXW8) ubiquitin-protein ligase, playing a critical role in the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain. Required to localize CUL7 to the Golgi apparatus in neurons. {ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Intolerance Scores
- loftool
- 0.861
- rvis_EVS
- -0.81
- rvis_percentile_EVS
- 12.02
Haploinsufficiency Scores
- pHI
- 0.183
- hipred
- N
- hipred_score
- 0.478
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.831
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Obsl1
- Phenotype
Gene ontology
- Biological process
- microtubule cytoskeleton organization;muscle contraction;cytoskeleton organization;Golgi organization;regulation of mitotic nuclear division;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;protein localization to Golgi apparatus;post-translational protein modification;sarcomere organization;cardiac muscle fiber development;positive regulation of dendrite morphogenesis;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;striated muscle myosin thick filament assembly
- Cellular component
- cytoplasm;Golgi apparatus;centrosome;cytosol;striated muscle thin filament;intercalated disc;sarcomere;Z disc;M band;perinuclear region of cytoplasm;3M complex
- Molecular function
- protein binding;cytoskeletal adaptor activity;structural constituent of muscle;actin filament binding;muscle alpha-actinin binding